CapWealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.8M Buy
137,077
+5
+0% +$1.17K 2.39% 11
2026
Q1
$33.5M Sell
137,072
-2,538
-2% -$591K 2.49% 8
2025
Q4
$28.9M Buy
139,610
+632
+0.5% +$125K 1.98% 20
2025
Q3
$25.8M Buy
138,978
+53
+0% +$9.08K 1.77% 22
2025
Q2
$21.2M Sell
138,925
-7,153
-5% -$1.1M 2.09% 19
2025
Q1
$24.2M Buy
146,078
+8,829
+6% +$1.38M 2.62% 12
2024
Q4
$19.8M Buy
137,249
+1,963
+1% +$304K 2.18% 21
2024
Q3
$21.9M Sell
135,286
-1,267
-0.9% -$202K 2.38% 12
2024
Q2
$20M Sell
136,553
-2,369
-2% -$352K 2.52% 14
2024
Q1
$22M Sell
138,922
-645
-0.5% -$103K 2.47% 15
2023
Q4
$21.9M Sell
139,567
-429
-0.3% -$65.8K 2.67% 14
2023
Q3
$21.8M Sell
139,996
-632
-0.4% -$104K 2.8% 10
2023
Q2
$23.3M Sell
140,628
-241
-0.2% -$38.9K 2.84% 9
2023
Q1
$21.8M Sell
140,869
-16,913
-11% -$2.73M 2.72% 10
2022
Q4
$27.9M Buy
157,782
+330
+0.2% +$57K 3.28% 6
2022
Q3
$25.7M Sell
157,452
-810
-0.5% -$137K 3.39% 5
2022
Q2
$28.1M Buy
158,262
+2,747
+2% +$489K 3.39% 4
2022
Q1
$27.6M Sell
155,515
-301
-0.2% -$51.2K 2.82% 8
2021
Q4
$26.7M Buy
155,816
+1,151
+0.7% +$188K 2.71% 8
2021
Q3
$25M Buy
154,665
+690
+0.4% +$118K 2.74% 7
2021
Q2
$25.4M Buy
153,975
+6,274
+4% +$1.04M 2.75% 7
2021
Q1
$24.3M Buy
147,701
+1,651
+1% +$267K 2.76% 8
2020
Q4
$23M Buy
146,050
+587
+0.4% +$86.6K 2.74% 7
2020
Q3
$21.7M Sell
145,463
-3,220
-2% -$476K 2.89% 10
2020
Q2
$20.9M Sell
148,683
-934
-0.6% -$136K 2.96% 10
2020
Q1
$19.6M Buy
149,617
+123
+0.1% +$17.5K 3.46% 7
2019
Q4
$21.8M Sell
149,494
-327
-0.2% -$44.4K 2.74% 8
2019
Q3
$19.4M Buy
149,821
+1,146
+0.8% +$151K 2.58% 13
2019
Q2
$20.7M Buy
148,675
+1,044
+0.7% +$145K 2.96% 10
2019
Q1
$20.6M Buy
147,631
+1,747
+1% +$234K 3.16% 9
2018
Q4
$18.8M Buy
145,884
+27,578
+23% +$3.85M 3.31% 7
2018
Q3
$16.3M Buy
118,306
+2,215
+2% +$294K 2.68% 10
2018
Q2
$14.1M Buy
116,091
+3,218
+3% +$401K 2.52% 14
2018
Q1
$14.5M Buy
112,873
+1,177
+1% +$159K 2.8% 11
2017
Q4
$15.6M Buy
111,696
+1,046
+0.9% +$146K 2.81% 13
2017
Q3
$14.4M Buy
110,650
+597
+0.5% +$79.1K 2.76% 11
2017
Q2
$14.6M Sell
110,053
-1,301
-1% -$166K 2.92% 7
2017
Q1
$13.9M Sell
111,354
-8,298
-7% -$991K 2.84% 9
2016
Q4
$13.8M Sell
119,652
-91
-0.1% -$10.5K 2.98% 7
2016
Q3
$14.1M Sell
119,743
-554
-0.5% -$67.2K 3.4% 6
2016
Q2
$14.6M Sell
120,297
-2,102
-2% -$239K 3.57% 3
2016
Q1
$13.2M Buy
122,399
+280
+0.2% +$29K 3.37% 4
2015
Q4
$12.5M Sell
122,119
-4,609
-4% -$464K 3.04% 8
2015
Q3
$11.8M Buy
126,728
+317
+0.3% +$30.7K 2.96% 7
2015
Q2
$12.3M Buy
126,411
+2,526
+2% +$253K 2.9% 9
2015
Q1
$12.5M Sell
123,885
-599
-0.5% -$60.9K 2.93% 6
2014
Q4
$13M Buy
124,484
+2,612
+2% +$275K 3.06% 6
2014
Q3
$13M Buy
121,872
+1,668
+1% +$173K 2.95% 6
2014
Q2
$12.6M Buy
120,204
+4,138
+4% +$418K 2.88% 6
2014
Q1
$11.4M Sell
116,066
-1
-0% -$93 3.07% 6
2013
Q4
$10.6M Sell
116,067
-9,940
-8% -$916K 2.68% 8
2013
Q3
$10.9M Buy
126,007
+1,379
+1% +$124K 3.04% 7
2013
Q2
$10.7M Buy
+124,628
New +$10.6M 3.12% 4

Other funds holding JNJ

CapWealth Advisors's JNJ Position: Q2 2026 in Review

CapWealth Advisors increased its Johnson & Johnson (JNJ) stake by 0% in Q2 2026, buying an estimated $1.17K and bringing the position to 137,077 shares worth $34.8M. The position accounts for 2.39% of the portfolio, ranked #11.

CapWealth Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • CapWealth Advisors held 137,077 shares of Johnson & Johnson worth $34.8M as of Q2 2026.
  • CapWealth Advisors bought 5 Johnson & Johnson shares in Q2 2026, an estimated $1.17K.
  • Johnson & Johnson made up 2.39% of CapWealth Advisors's portfolio in Q2 2026, its #11 holding.
  • CapWealth Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on CapWealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.